ECSP034523A - Compuestos heteroaromaticos biciclicos - Google Patents

Compuestos heteroaromaticos biciclicos

Info

Publication number
ECSP034523A
ECSP034523A EC2003004523A ECSP034523A ECSP034523A EC SP034523 A ECSP034523 A EC SP034523A EC 2003004523 A EC2003004523 A EC 2003004523A EC SP034523 A ECSP034523 A EC SP034523A EC SP034523 A ECSP034523 A EC SP034523A
Authority
EC
Ecuador
Prior art keywords
heteroaryl
aryl
bicycle
heteroaromatic compounds
heterocycloalkyl
Prior art date
Application number
EC2003004523A
Other languages
English (en)
Inventor
Cornelis Marius Timmers
Willem Frederik Johan Karstens
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP034523A publication Critical patent/ECSP034523A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Este invento está hecho de un compuesto heteroaromático bicíclico de acuerdo con la fórmula general I o una sal de los mismos que sea aceptable desde el punto de vista farmacéutico, donde R1 es (3-8)cicloalquil. (2-7C)heterocicloalquil, (6-14C)aril o (4-13C)heteroaril; de preferencia, R1 es (6-14C)aril o (4-13C)heteroarilo; R2 es (1-4)alquil, (2-4C)alquinil, o (6-14C)aril o (4-13C)heteroarilo R3 es (1-8C)alquil. (3-8C)cicloalquil, (2-7C)heterocicloalquil, (6-14C)aril o (4-13C)heteroaril; Y es CH o N; Z es NH2 u OH; A es S, N(H), N(R4). O un enlace. XII-X2 es C=C, (C(O)-NH, NH-C(O), O-C)O). o S u O. Los compuestos de la invención pueden ser utilizados en terapias de regulación de fertilidad.
EC2003004523A 2000-09-22 2003-03-21 Compuestos heteroaromaticos biciclicos ECSP034523A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00203287 2000-09-22

Publications (1)

Publication Number Publication Date
ECSP034523A true ECSP034523A (es) 2003-04-25

Family

ID=8172046

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004523A ECSP034523A (es) 2000-09-22 2003-03-21 Compuestos heteroaromaticos biciclicos

Country Status (32)

Country Link
US (2) US7229990B2 (es)
EP (2) EP1886999A3 (es)
JP (1) JP4977940B2 (es)
KR (1) KR100860040B1 (es)
CN (1) CN1247594C (es)
AR (1) AR030784A1 (es)
AT (1) ATE384726T1 (es)
AU (2) AU1392902A (es)
BR (1) BR0113987A (es)
CA (1) CA2422054C (es)
CY (1) CY1107308T1 (es)
CZ (1) CZ297136B6 (es)
DE (1) DE60132607T2 (es)
DK (1) DK1322651T3 (es)
EC (1) ECSP034523A (es)
ES (1) ES2299524T3 (es)
HK (1) HK1054942A1 (es)
HR (1) HRP20030220B1 (es)
HU (1) HU229422B1 (es)
IL (2) IL154624A0 (es)
IS (1) IS2531B (es)
MX (1) MXPA03002478A (es)
NO (1) NO328683B1 (es)
NZ (1) NZ524444A (es)
PE (1) PE20020537A1 (es)
PL (1) PL207755B1 (es)
PT (1) PT1322651E (es)
RU (1) RU2271360C2 (es)
SK (1) SK287554B6 (es)
TW (1) TWI290143B (es)
WO (1) WO2002024703A1 (es)
ZA (1) ZA200301588B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002024703A1 (en) * 2000-09-22 2002-03-28 Akzo Nobel N.V. Bicyclic heteroaromatic compounds
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
US7674822B2 (en) 2004-11-24 2010-03-09 Wyeth PTP1b inhibitors
US7723342B2 (en) * 2005-05-17 2010-05-25 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AU2007254165A1 (en) * 2006-05-17 2007-11-29 Forschungsverbund Berlin E.V. Pyrimidine low molecular weight ligands for modulating hormone receptors
WO2009132980A1 (en) 2008-04-29 2009-11-05 F. Hoffmann-La Roche Ag Pyrimidinyl pyridone inhibitors of jnk.
US8741259B2 (en) * 2008-10-20 2014-06-03 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
CN102791705B (zh) 2010-04-08 2016-08-03 美国政府(由卫生和人类服务部的部长所代表) 用于tsh受体的反向激动剂和中性拮抗剂
CN108707151B (zh) 2011-08-23 2022-06-03 阿萨纳生物科技有限责任公司 嘧啶并-哒嗪酮化合物及其用途
CN113680386B (zh) * 2021-08-23 2023-08-11 深圳湾实验室坪山生物医药研发转化中心 氮杂环卡宾-方酰胺双功能催化剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2891544B2 (ja) * 1994-06-16 1999-05-17 ファイザー・インコーポレーテッド ピラゾロおよびピロロピリジン類
EP0920319A4 (en) * 1996-05-20 2002-05-02 Merck & Co Inc GONADOLIBERIN ANTAGONISTS
TW564247B (en) * 1999-04-08 2003-12-01 Akzo Nobel Nv Bicyclic heteraromatic compound
WO2002024703A1 (en) * 2000-09-22 2002-03-28 Akzo Nobel N.V. Bicyclic heteroaromatic compounds

Also Published As

Publication number Publication date
IS2531B (is) 2009-07-15
CZ2003828A3 (cs) 2003-08-13
HK1054942A1 (en) 2003-12-19
EP1322651A1 (en) 2003-07-02
HU229422B1 (hu) 2013-12-30
EP1886999A8 (en) 2010-08-04
AU2002213929B2 (en) 2006-04-13
AR030784A1 (es) 2003-09-03
ES2299524T3 (es) 2008-06-01
TWI290143B (en) 2007-11-21
BR0113987A (pt) 2003-08-12
PT1322651E (pt) 2008-02-28
ZA200301588B (en) 2004-06-22
CZ297136B6 (cs) 2006-09-13
NO20031314L (no) 2003-03-21
US7229990B2 (en) 2007-06-12
CN1247594C (zh) 2006-03-29
AU1392902A (en) 2002-04-02
JP4977940B2 (ja) 2012-07-18
DE60132607D1 (de) 2008-03-13
KR100860040B1 (ko) 2008-09-25
US7618963B2 (en) 2009-11-17
HRP20030220A2 (en) 2003-06-30
NO20031314D0 (no) 2003-03-21
CA2422054C (en) 2011-01-11
DK1322651T3 (da) 2008-06-02
US20030225113A1 (en) 2003-12-04
IS6732A (is) 2003-02-28
HRP20030220B1 (en) 2011-10-31
EP1322651B1 (en) 2008-01-23
PE20020537A1 (es) 2002-06-20
CA2422054A1 (en) 2002-03-28
CN1462273A (zh) 2003-12-17
HUP0302648A3 (en) 2004-11-29
PL207755B1 (pl) 2011-01-31
DE60132607T2 (de) 2009-01-29
HUP0302648A2 (hu) 2003-11-28
RU2271360C2 (ru) 2006-03-10
NZ524444A (en) 2004-03-26
US20070197527A1 (en) 2007-08-23
EP1886999A2 (en) 2008-02-13
NO328683B1 (no) 2010-04-26
SK287554B6 (sk) 2011-01-04
SK3312003A3 (en) 2003-08-05
IL154624A0 (en) 2003-09-17
JP2004509896A (ja) 2004-04-02
EP1886999A3 (en) 2008-03-12
PL360675A1 (en) 2004-09-20
MXPA03002478A (es) 2004-05-05
WO2002024703A1 (en) 2002-03-28
KR20030040483A (ko) 2003-05-22
IL154624A (en) 2009-09-01
CY1107308T1 (el) 2012-11-21
ATE384726T1 (de) 2008-02-15

Similar Documents

Publication Publication Date Title
ECSP034523A (es) Compuestos heteroaromaticos biciclicos
DE69200766D1 (en) Phenylamidinderivate als plättchenaggregationsinhibitoren.
DK0462884T3 (da) TRH-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder disse
HRP20080490T3 (en) 3-fluoro-piperidines as nmda/nr2b antagonists
PT784974E (pt) Preparacao de derivados de xantina numa dispersao solida
NO944311L (no) Substituerte indoler og azaindoler som angiotensin-II-antagonister
BG103863A (en) Indazolamide compounds as serotoninergic forms
DE69426602T2 (de) 2,3-diaminopropionsäurederivate
ATE171188T1 (de) In 15-stellung substituierte 4-azasteroide
ATE172463T1 (de) Pyrrolocarbazol
CO4920251A1 (es) Compuestos hexahidro 1 h. -pirrolizina 7 a. -heterociclico- substituidos utiles en el control de la transmision sinaptica quimica
TW427993B (en) New cephem compounds
NO175776C (no) 1-aminopropandiol-2,3 med höy renhet, samt fremgangsmåte for fremstilling av forbindelsen
DK0505778T3 (da) Derivater af imidazol-2-oner samt fremgangsmåde til fremstilling deraf
DE69319859D1 (de) Neue tetracyclische verbindungen
GB9930358D0 (en) Process for the preparation of chemical compounds
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
CR8456A (es) Inhibidores heterociclil amino de 11- beta- hidroxiesteroide deshidrogenasa tipo 1
SV2001000050A (es) Compuestos farmaceuticos caso n.g.1336
EP1650199A4 (en) SULPHONAMIDE DERIVATIVE WITH ISOXAZOL RING
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
CO4810228A1 (es) Derivados de pirazol piridazina, procesos para su preparacion y composiciones farmaceuticas que los contienen
EP0794185A4 (en) BICYCLIC THIAZOLE COMPOUND
TH13138A (th) พิเพอราซินิลและพิเพอริดินิลไซโคลเฮกซานอล
UA10041A (uk) СПОСІБ ОДЕРЖАННЯ alРha, omega - ДІАМІНООКСІОЛІГООКСААЛКАНІВ